Jefferies Downgrades MEI Pharma (MEIP) to Underperform
Tweet
Share
E-mailGet Alerts MEIP Hot Sheet
Price: $3.07 --0%
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Jefferies analyst Chris Howerton downgraded MEI Pharma (NASDAQ: MEIP) from Hold to Underperform with a price target of $0.10 (from $0.40).
For an analyst ratings summary and ratings history on MEI Pharma click here. For more ratings news on MEI Pharma click here.
Shares of MEI Pharma closed at $0.35 yesterday.
You May Also Be Interested In
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
- Sansera Engineering Ltd (SANSERA:IN) PT Raised to INR4,250 at ICICI Securities
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
